PTCL Clinical Trials in Shanghai
3 recruitingShanghai, China
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Hodgkin LymphomaNon-Hodgkin LymphomaLymphoma+4 more
AstraZeneca161 enrolled35 locationsNCT06137144
Recruiting
Early Phase 1
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
DLBCLNK/T-cell LymphomaPeripheral T-cell Lymphoma (PTCL)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine24 enrolled1 locationNCT07162012
Recruiting
Phase 1Phase 2
CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
T-cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital36 enrolled3 locationsNCT07022964